clinicalprofessionals.co.uk
Astellas announce first dosing of patient in late-stage menopause trial - Clinical Professionals
Astellas Pharma has announced the initiation and dosing of the first patient in their SKYLIGHT1 Phase III pivotal trial for fezolinetant.